WO2004048970A1 - Uses of optical projection tomography methods and apparatus - Google Patents
Uses of optical projection tomography methods and apparatus Download PDFInfo
- Publication number
- WO2004048970A1 WO2004048970A1 PCT/GB2003/005143 GB0305143W WO2004048970A1 WO 2004048970 A1 WO2004048970 A1 WO 2004048970A1 GB 0305143 W GB0305143 W GB 0305143W WO 2004048970 A1 WO2004048970 A1 WO 2004048970A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- analysis
- tissues
- research
- specimen
- distribution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 54
- 230000003287 optical effect Effects 0.000 title claims abstract description 50
- 238000003325 tomography Methods 0.000 title abstract description 6
- 238000004458 analytical method Methods 0.000 claims abstract description 214
- 210000001519 tissue Anatomy 0.000 claims description 170
- 238000011160 research Methods 0.000 claims description 65
- 238000009826 distribution Methods 0.000 claims description 56
- 239000000126 substance Substances 0.000 claims description 46
- 238000003384 imaging method Methods 0.000 claims description 41
- 108090000623 proteins and genes Proteins 0.000 claims description 39
- 206010028980 Neoplasm Diseases 0.000 claims description 30
- 230000000694 effects Effects 0.000 claims description 28
- 238000001574 biopsy Methods 0.000 claims description 24
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 238000010186 staining Methods 0.000 claims description 19
- 241001465754 Metazoa Species 0.000 claims description 18
- 230000005856 abnormality Effects 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 18
- 230000014509 gene expression Effects 0.000 claims description 15
- 241000196324 Embryophyta Species 0.000 claims description 12
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 12
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 12
- 230000002159 abnormal effect Effects 0.000 claims description 12
- 201000011510 cancer Diseases 0.000 claims description 12
- 230000003197 catalytic effect Effects 0.000 claims description 12
- 238000011161 development Methods 0.000 claims description 12
- 230000018109 developmental process Effects 0.000 claims description 12
- 238000003745 diagnosis Methods 0.000 claims description 12
- 239000005090 green fluorescent protein Substances 0.000 claims description 12
- 238000012986 modification Methods 0.000 claims description 12
- 230000004048 modification Effects 0.000 claims description 12
- 210000005036 nerve Anatomy 0.000 claims description 12
- 230000035479 physiological effects, processes and functions Effects 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 12
- 230000002269 spontaneous effect Effects 0.000 claims description 12
- 230000009261 transgenic effect Effects 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 8
- 238000013459 approach Methods 0.000 claims description 7
- 238000009396 hybridization Methods 0.000 claims description 7
- 238000003364 immunohistochemistry Methods 0.000 claims description 7
- 238000011065 in-situ storage Methods 0.000 claims description 7
- 229940097275 indigo Drugs 0.000 claims description 7
- 241000251468 Actinopterygii Species 0.000 claims description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 6
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 6
- 241000269332 Ambystoma mexicanum Species 0.000 claims description 6
- 241000271566 Aves Species 0.000 claims description 6
- 241000282472 Canis lupus familiaris Species 0.000 claims description 6
- 241000251730 Chondrichthyes Species 0.000 claims description 6
- 208000027205 Congenital disease Diseases 0.000 claims description 6
- 241000938605 Crocodylia Species 0.000 claims description 6
- 241000252212 Danio rerio Species 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 241000282326 Felis catus Species 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 208000019468 Iatrogenic Disease Diseases 0.000 claims description 6
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 6
- 241000124008 Mammalia Species 0.000 claims description 6
- 241000244206 Nematoda Species 0.000 claims description 6
- 241000286209 Phasianidae Species 0.000 claims description 6
- 241000288906 Primates Species 0.000 claims description 6
- 241000283984 Rodentia Species 0.000 claims description 6
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims description 6
- 241000269370 Xenopus <genus> Species 0.000 claims description 6
- 208000037919 acquired disease Diseases 0.000 claims description 6
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 claims description 6
- 238000011888 autopsy Methods 0.000 claims description 6
- -1 b-galactosidase Proteins 0.000 claims description 6
- 210000004556 brain Anatomy 0.000 claims description 6
- 210000005013 brain tissue Anatomy 0.000 claims description 6
- 230000022131 cell cycle Effects 0.000 claims description 6
- 230000030833 cell death Effects 0.000 claims description 6
- 230000012292 cell migration Effects 0.000 claims description 6
- 230000004663 cell proliferation Effects 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 235000013330 chicken meat Nutrition 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000003412 degenerative effect Effects 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 6
- 230000013020 embryo development Effects 0.000 claims description 6
- 230000002124 endocrine Effects 0.000 claims description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims description 6
- 238000003197 gene knockdown Methods 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 230000000642 iatrogenic effect Effects 0.000 claims description 6
- 208000036260 idiopathic disease Diseases 0.000 claims description 6
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 6
- 208000015181 infectious disease Diseases 0.000 claims description 6
- 230000002458 infectious effect Effects 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 238000011862 kidney biopsy Methods 0.000 claims description 6
- 238000012317 liver biopsy Methods 0.000 claims description 6
- 210000001165 lymph node Anatomy 0.000 claims description 6
- 230000002503 metabolic effect Effects 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 238000001964 muscle biopsy Methods 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 6
- 230000001613 neoplastic effect Effects 0.000 claims description 6
- 238000012634 optical imaging Methods 0.000 claims description 6
- 230000007170 pathology Effects 0.000 claims description 6
- 230000037361 pathway Effects 0.000 claims description 6
- 230000035790 physiological processes and functions Effects 0.000 claims description 6
- 230000035935 pregnancy Effects 0.000 claims description 6
- 210000002307 prostate Anatomy 0.000 claims description 6
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 6
- 210000000130 stem cell Anatomy 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 208000011580 syndromic disease Diseases 0.000 claims description 6
- 230000000472 traumatic effect Effects 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 230000002792 vascular Effects 0.000 claims description 6
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 claims description 5
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 230000033001 locomotion Effects 0.000 description 8
- 239000002184 metal Substances 0.000 description 8
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005286 illumination Methods 0.000 description 4
- 238000000386 microscopy Methods 0.000 description 4
- 230000005484 gravity Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 229960002903 benzyl benzoate Drugs 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
- G01N2015/1472—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle with colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/02—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a plurality of sample containers moved by a conveyor system past one or more treatment or analysis stations
- G01N35/04—Details of the conveyor system
- G01N2035/0474—Details of actuating means for conveyors or pipettes
- G01N2035/0477—Magnetic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
Definitions
- the present invention relates to uses of optical projection tomography methods and apparatus.
- analyses and procedures of the present invention include:
- 5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
- any fluorescent substances such as: Alexa dyes, FITC, rhodamine,
- GFP green fluorescent protein
- invertebrates nematode worms vertebrates all types of fish including teleosts, such as zebrafish, and chondrycthes including sharks
- amphibians including the genus Xenopus and axolotls
- reptiles birds including chickens and quails
- all mammals including all rodents, dogs, cats and all primates, including human
- embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
- Analysis of any tissues for the purpose of genomics research including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the structure or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
- Analysis of any tissue for pharmaceutical research including: the analysis of pharmaceutical substances (such as drugs, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the structure or morphology of tissues.
- pharmaceutical substances such as drugs, molecules, proteins, antibodies
- tissues for medical research including: research into the genetics, development, physiology, structure and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
- Analysis of tissues for medical diagnosis, treatment or monitoring including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal structure or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
- samples for use in the present invention may be prepared as described in the earlier patent application and/or employing conventional pathological and histological techniques and procedures well known to persons skilled in the art.
- a rotary stage for use in imaging a specimen from a plurality of directions, the rotary stage comprising specimen support means including a rotatable member operative to rotate a specimen to be imaged about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the specimen support means is disposed above a stationary imaging chamber for receiving the specimen immersed in optical imaging fluid within the chamber.
- the rotary stage may be used with a separate microscope and associated hardware and software that allows three dimensional imaging of a specimen, such as a biological tissue.
- a specimen support means spaced from the microscope, the positioning of the specimen can be easily adjusted due to improved accessibility of the specimen holder.
- the longest axis of the specimen is substantially parallel to gravity when held within the specimen support means. This allows the specimen to be held at one point only, again assisting with location of the specimen within the specimen support means, and avoids deflection of the specimen through gravitational effects, as such deflection can cause unwanted distortion of the specimen shape and affect the accuracy and resolution of the image obtained.
- the chamber shape is not limited to a rotationally symmetric shape.
- the chamber has at least one planar face on which light impinges to image the specimen. Use of a flat planar face with no imperfections or undulations ensures that image distortion due to refraction of light is reduced.
- the chamber may be formed as a transparent hollow cuboid and arranged such that two opposing sides of the cuboid are substantially perpendicular to the optical axis along which light is emitted from the specimen so that a large cross-sectional area is presented to the optical axis.
- the selection of such a chamber with a square cross-section ensures that the amount of light refracted before passing through the specimen is substantially reduced over prior art cylindrical rotating chambers and thus image quality is improved.
- One wall or face of the chamber may be shaped so as to refract light in a desired way, for example to provide a magnifying effect.
- the rotary stage may f rther comprise a pivotally mounted adjustment means, such as a lever, having a spigot extending therefrom, the spigot being arranged in use so as to engage with a specimen to alter its position relative to the axis of rotation.
- the rotary stage may further comprise a prism positioned so as to receive light after the latter has illuminated the specimen, the prism acting to deflect light through 90° to enable the light to be received by a microscope with a vertical optical axis.
- a prism By using a prism, the optical path to the microscope does not need to be straight, and thus modification of existing microscopes is not needed for use with a rotary stage in accordance with the present invention.
- the rotatable member of the specimen support means may be carried on an adjustable platform, the position of which relative to the horizontal is variable. This allows the axis of rotation to be adjusted relative to an optical axis so that if required a 90° angle is set between the optical axis and the axis of rotation. This is particularly useful for three dimensional imaging.
- the adjustable platform is preferably vertically adjustable so as to raise and lower the rotating member relative to the optical axis, so allowing a specimen to be lowered into or out of an optical path of light.
- the rotatable member is formed to enable the specimen to be hung, suspended or to downwardly depend from the lower end of the rotatable member.
- a specimen is appropriately prepared with a magnetisable metal mount
- attachment of the specimen to the specimen support means is then straightforward, just relying on magnetic attraction and not on a delicate fixing.
- This is of advantage as typically the specimens are rather small and delicate, usually with a diameter in the range l-20mm, and securing them in a holder using a screw thread can be complicated.
- a method of obtaining an image of a specimen comprising rotating the specimen about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the rotating specimen is immersed in fluid within a stationary optical chamber.
- FIGS 1 to 18 relate to an aspect of the invention in which:
- Figure 1 is a perspective view of optical imaging apparatus comprising a rotary stage in accordance with the present invention together with a microscope;
- Figure 2 shows a schematic illustration of how such imaging apparatus is controlled when acquiring digital images
- Figure 3 shows a front perspective view of the apparatus
- FIGS. 4(a) and 4(b) are schematic diagrams used to illustrate the most appropriate working configuration of the apparatus
- Figures 5(a), 5(b), 5(c) and 5(d) illustrate attachment of a specimen to the specimen support means and alignment of a region of interest
- Figures 6(a), 6(b) and 6(c) are schematic diagrams used to explain resolution of the apparatus;
- Figures 7(a) shows a cross-section through a prior art specimen containing tube, with Figures 7(b) and 7(c) showing two specimen chambers as used in the present invention;
- Figures 8(a) and 8(b) show a partial plan view along line VIII- VIII of Figure 1 , illustrating use of a pivotally mounted lever to adjust specimen position;
- Figure 9 is a perspective view of modified optical imaging apparatus according to the invention.
- Figure 10 is a diagram illustrating the apparatus of Figure 9,
- Figures 11a, lib, lie, 12a, 12b, 13a, 13b and 14 illustrate positioning and viewing of the specimen image in the apparatus of Figure 9,
- FIGs 15 and 16 illustrate a collimated illumination means which may be used in the apparatus of Figure 1 or Figure 9,
- Figure 17 indicates a way of selecting wavelength from a light source in the optical stage of Figure 1 or Figure 9;
- Figure 18 illustrates a modification of the apparatus shown in Figure 16.
- Figure 1 shows optical imaging apparatus in the form of an OPT scanner comprising a rotary stage 10 and a long working-distance or dissecting microscope 12, separate from the rotary stage 10.
- the rotary stage 10 has a support 14, a pivotally mounted lever 16, an iris and optical diffoser 20, and a quartz prism 22.
- the support 14, iris and diffuser 20, and prism 22 are fixed to a base 24 of the stage 10, as is a holder 25 for receiving a transparent chamber 26, or cuvette, of a generally cuboid shape.
- the cuvette 26 contains a fluid with suitable optical properties for imaging a specimen 28 suspended within the cuvette, an appropriate fluid being a mixture of benzyl alcohol and benzyl benzoate.
- This apparatus can be used for brightf ⁇ eld, darkfield and fluorescence imaging but is particularly appropriate where a three dimensional (3D) image of the specimen is created from a series of images taken at different angles, and for specimens too large to be imaged by confocal microscopy.
- 3D three dimensional
- Light passes along optical axis 29, passing through the centre of the iris arid diffuser 20, and through the specimen 28 and is deflected through right angles by the prism 22 to enter an objective 30 of the microscope 12.
- the prism 22 can rest beneath the microscope objective 30.
- Using a prism allows a vertically oriented microscope to image the specimen.
- the prism 22 can be omitted where the microscope objective is parallel to the optical axis.
- the iris and diffuser 20 control the amount of light passing from a light source (not shown) to reach the specimen 28 and provide even illumination.
- the support 14 carries a circular boss on which is pivotally mounted, about an axis 90 ( Figure 4), a tilting plate 33 upon which is slidable, upwards and downwards, a plate 32.
- the plate 32 carries an adjustable platform 34 cantilevered horizontally from the plate 32. The angle of the platform 34 can be altered relative to the horizontal using a tilt adjuster 36 and the vertical position of the platform 34 can be varied by means of a vertical adjuster 40.
- a stepper motor 42 is mounted on the platform 34, with a rotatable motor shaft 44 of the motor extending through the platform 34.
- a magnet 46 (a permanent magnet or an electro-magnet) is attached to the lower end of the shaft 44 and carries the specimen 28 to be imaged.
- the stepper motor 42 rotates the shaft 44 with a step size of 0.9 degrees, providing up to 400 imaging positions of the specimen.
- a series of digital images of the elongate specimen 28 is taken by indexing the shaft 44 to its successive rotational positions, and thus positioning the specimen in successive rotational positions whilst the specimen is suspended within the cuvette 26, the cuvette remaining stationary.
- the rod-like specimen 28 By mounting the stepper motor 42 with its axis of rotation vertical, the rod-like specimen 28 only needs to be secured at one point, typically its uppermost end, for controlled rotation of the specimen to occur.
- the specimen 28 is immersed in the liquid, supported from above by the magnet 46, by using the vertical adjuster 40 to lower the platform.
- This vertical orientation of the specimen and the rotational axis avoids the use of O-rings or other mechanical arrangements which would be necessary to connect the dry motor to the immersed specimen, and secondly it ensures that the specimen is not deflected off its axis of rotation by gravity as the elongate specimen has its major axis parallel to the force of gravity.
- Avoiding distortion effects to the specimen by having a vertically orientated specimen is particularly important for obtaining accurate 3D images, particularly for larger specimens.
- Use of a generally upright hollow cuboid as the imaging chamber 26 around the specimen 28 ensures that the surface area of the imaging liquid is limited, reducing evaporation of the liquid.
- much larger specimens, typically l-20mm in diameter can be imaged by using such a fixed chamber without loss of digital signal quality.
- a digital camera 52 ( Figure 2) is attached to the microscope 12 and produces a digital image of the specimen as imaged by the microscope from light that has travelled along the optical axis 29, and been transmitted through the chamber and specimen.
- a series of digital images are taken of the specimen from different angles and this digital information is fed into an algorithm which uses a mathematical formula to reconstruct the structure of the specimen in three dimensions.
- the images are obtained using the control elements as set out in Figure 2.
- a computer 50 carrying digital image acquisition software is in two-way communication with the digital camera 52 attached to the microscope 12 which receives images from a specimen of interest.
- the computer 50 controls filter wheels 56 attached to the microscope 12 to alter the wavelength of radiation that is detected.
- the computer acquisition software is shown diagrammatically in Figure 2 as software 58 to control image-capture from the digital camera, a program 54 to control the imaging software, the rotary stage and the filter wheel software, software 48 to control the filter wheels and software 64 to convert the image files into a 3D reconstruction.
- the computer is also in two-way communication with electronic control circuits 60 connected to the rotary stage 10 and controls the circuits 60 to adjust the orientation of the specimen as required during image capture of successive images.
- the computer can control the entire imaging process, undertaking image- processing to determine the size of the specimen, its alignment, whether it is in focus etc., and adjusting the specimen position before performing the rotational imaging. This complete automation of the imaging process is particularly desirable for large scale gene expression mapping projects in which many such devices could be ran in parallel.
- the circuitry 60 responsive to the computer to control the stepper motor 42 is commercially available for most popular computer systems.
- the circuitry 60 connects to the computer 50 and is responsive to signals from the computer 50 to control a variety of mechanical devices (stepper motors, solenoids etc.).
- software performs the following functions: (1) determine the axis of rotation (through the symmetry which exists between each pair of images which were taken at 180 degrees to each other), (2) reorganise the stack of images into an orthogonal stack of projection images (in which image represents a single section through the specimen, viewed from all the different angles captured), (3) perform the mathematical processing on each projection image, to recreate that section through the specimen, (4) combine all the calculated section images into a 3D format. Reconstructions can be created both from transmitted light and from fluorescently-emitted light.
- a front view of the rotary stage 10 is shown in Figure 3.
- the tilt adjuster 36 varies the angle of tilt of the platform 34 about the axis 90 which is below the lower end of the shaft 44 and is approximately at the height of the specimen so that tilt adjustment does not move the specimen substantially.
- the axis 90 may intersect the optical axis 29.
- Tilt adjustment (illustrated- by the double-headed arrow 92 in Figure 3) ensures that the rotational axis 94 of the stepper motor 42 is accurately perpendicular to the optical axis 29.
- the position of the platform 34 relative to the base 24 is adjusted using the vertical adjuster 40 which uses a rack and pinion arrangement to raise and lower the platform 34 in the adjusted direction of the rotational axis 94.
- a specimen carried on the magnet attached to the end of the shaft 44 can be lowered a required depth into the imaging chamber for imaging and raised out of the chamber once imaging has been performed.
- the vertical position of the specimen during imaging an also be altered in this way if required.
- specimens can be loaded into or out of the rotary stage.
- the apparatus When the apparatus is set up, it is aligned such that the optical axis of the microscope passes through the prism, and through the centre of the imaging chamber.
- the alignment can need adjusting as the specimen becomes slightly displaced away from the centre of the field-of-view.
- the raising/lowering mechanism mentioned above can be adjusted to correct for this misalignment in the vertical direction.
- 3D reconstruction of the specimen using the mathematical processing will be of very poor quality unless the angle between the optical axis and the rotational axis is exactly 90°.
- the tilt adjuster 36 allows the axis of rotation 94 to be tilted slightly so as to ensure the angle is exactly 90°.
- the tilt adjuster 36 typically relies upon a screw-thread mechanism to urge the platform 34 to one side.
- a calibration sample is used to adjust the angle of tilt, with the calibration sample containing a number of small particles whose trajectories can be monitored on a computer screen while the shaft rotates. If the axis of rotation is not perfectly perpendicular to the optical axis, the trajectory of the particle appears as an ellipse, see Figure 4(a) which shows the view along the optical axis as the shaft rotates about the axis 94. When the axis is correctly aligned, the particle is seen to move from side to side, with no vertical component to the motion, see Figure 4(b).
- Figure 5 shows the magnetic mounting system used which relies upon magnetic attraction between a metal disc 110 attached to a specimen 112 and the cylindrical magnet 46 permanently attached to the lower end of the rotatable shaft 44 of the stepper motor 42.
- Each specimen has a small magnetisable metal disc glued at one end during specimen preparation. The disc is then attached to the magnet when imaging is to be undertaken and the specimen supported as a result of the magnetic attraction between the disc and the magnet.
- the magnet does not need to be strongly magnetised to support their weight.
- One advantage of the magnet system over, for example, a screw-in system is that the small size of the disc and specimen necessitates handling with forceps or tweezers.
- a region of interest 122 in a specimen 112 must be centred on the axis of rotation 94, i.e. not move as the shaft rotates. If the region of interest, or the whole specimen, is off-centre and oscillates from side-to-side during a rotational image capture, then the magnification necessary to keep it in view will be low.
- Figure 6(a) The two shapes 130, 132 represent the specimen 112 during rotation, at its most extreme positions to the left and right. When the specimen 112 is perfectly centred, it spins on its own axis, see Figure 6(b). This presents a smaller width across the field-of-view, and so the magnification can be increased to provide an image with higher resolution, see Figure 6(c).
- Adjustment of the specimen 112 relative to the axis of rotation 94 is simplified by the magnetic attachment.
- the centre of the disc can be offset relative to the rotational axis 94.
- the region of interest 122 within the specimen 112 is not centred on the axis of rotation but rather is displaced to the left. If the motor shaft is rotated through 180°, the region of interest 122 is now visible on the right hand side of the axis of rotation, see Figure 5(b).
- FIG. 7(a) showing a cross-section through the prior art cylindrical tube 136 (which is suspended horizontally), and Figure 7(b) showing the chamber 26 used in the present embodiment.
- the imaging chamber 26 is chosen to be generally cuboid and to be square in cross-sectional shape, and is made from quartz, glass or other suitably transparent material.
- Each chamber /tube contains a specimen 141 bathed in liquid 143 with suitable optical properties to allow imaging of the specimen.
- the flat sides 142, 142' 144, 144' of chamber 26 reduce refractive distortion of the image and allow larger specimens to be imaged. This is because the mutually parallel walls 142, 142' of the square cross-section chamber are aligned perpendicular to the optical axis 29 and provide a greater imaging area over which non- refraction of light occurs than for the circular tube 136, which only has a very small part of its circumference at normal incidence to the light. Thus a good image can be formed across a width of more than 10mm for the chamber 26, improving the amount of signal received from the sample and reducing distortion due to refraction.
- Figure 7c illustrates a modification of the sample chamber of Figure 7b.
- the sample chamber 26' has a square internal cross-section but one wall 140 is shaped to provide a plano-convex lens to refract light leaving the chamber.
- the shaping causes a desired refraction, in the case of Figure 7c a magnifying effect.
- Figure 8(a) shows the lever 16 in its usual position, pushed away from the magnet 46 and metal specimen mount 110. If the specimen is displaced too far to one side (as illustrated) the lever 16 can be moved about pivot 164 so that spigot 166 engages with metal mount 110 to push the specimen into the correct position ( Figure 8b). This is done while the specimen position is monitored on the computer screen. Since the stepper motor can be carefully controlled through manual switches, the specimen trajectory during rotation can be observed and the motor stopped when the specimen is maximally to one side. The specimen is then centred using the lever 16, and the process repeated until alignment of the specimen relative to the optical axis is complete. The lever 16 is organised so as to produce a "geared-down" movement to the specimen, which makes it easier to control the adjustment.
- the pivot 164 is attached to the main motor stage. It is fixed to the stage by a support which ensures the spigot 166 is at the correct height to contact the metal mount, just below the magnet. This way, the spigot 166 remains at the correct height irrespective of the height chosen to image the specimen.
- the apparatus described herein is suitable for 3D microscopy and also rotational microscopy for any purpose, on biological specimens and specimens from other fields such as ' material science.
- the refractive index should be uniform throughout the specimen.
- a clearing solvent a mixture of benzyl alcohol and benzyl benzoate
- BABB a mixture of benzyl alcohol and benzyl benzoate
- the apparatus is also suitable for undertaking 3D mapping of gene expression patterns (RNA and/or protein distribution) in biological tissue, whilst allowing the specimen to be used for other analysis after imaging.
- Specimen imaging using the apparatus is relatively quick, taking around 20 minutes.
- preparing, embedding, sectioning, mounting, staining and digitising real histological sections takes days and produces hundreds of digital 2D sections, but no guaranteed way to align them with each other to recreate the original 3D shape.
- the histological sections tend to stretch significantly, such that even if all the sections can be fitted onto each other to create a 3D shape, the final result will not accurately reflect the shape of the original specimen.
- the results obtained using the apparatus are very similar to the real physical shape of the specimen, the only difference from physical sections being reduced resolution. As the data generated by the apparatus is genuinely 3D it can be virtually resectioned in any orientation, or rendered in 3D.
- FIG. 9 A modified construction of rotary stage is illustrated in Figure 9 where parts corresponding to those of Figure 1 bear the same reference numerals.
- three-dimensional adjustment of the position of the stepper motor 42 is achieved by the use of three secondary stepper motors 150, 152, 154.
- No tilt adjuster for the motor 42 is present. Instead, the prism is capable of being manually adjusted by controlled tilting about a transverse horizontal axis 23.
- the important stepper motors are the motors 150 and 154.
- the motor 152 can be replaced by a manual vertical adjuster 40.
- the secondary stepper motors 150, 152, 154 allow sub-micron accuracy adjustment of the 3D position of the primary stepper motor 42, along the orientations labelled as x, y and z.
- stepper motors 150, 152, 154 are controlled by the same computer which controls the primary motor 42. This is illustrated in Figure 10 where the computer 50 drives the four motors through motor driving circuits 156.
- the z-axis is considered parallel to the optical axis 29. Movements along this axis effectively alter the focus of the system. Movements along the other two axes alter which part of the specimen coincides with the centre of the optical axis 29.
- the computer-controlled translation by the three secondary motors 150, 152, 154 has the following advantages:
- ROI region of interest
- the software needs to calculate the positions of:
- magnification is set low enough such that during a full rotation the ROI stays within the field-of-view of the camera.
- the system is previously calibrated such that it is known how many pulses to the x-stepper motor correspond to a given displacement as measured in pixels on the computer screen. This relationship is determined for each magnification.
- the computer then presents the user with four images of the specimen, rotated to 0, 90, 180 and 270 degrees (as seen in Figures 11a to lie). In Figure 11a, each outer rectangle represents the imaging window on the computer screen and the spot represents the region of interest 122 of the specimen.
- Figure 1 lb shows views along the optical axis (as seen on the computer screen) for low magnification
- Figure l ie shows plan views along the axis of rotation 94. The user then uses the computer mouse (or equivalent) to indicate where the ROI is in each image.
- Figure 12 shows how the positioning system can move the stepper motor 42 in both the x and z dimensions, and can therefore compensate for the ROI being off-centre.
- the x and z movements of the motor 42 are controlled by the computer to ensure that the ROI 122 remains in a fixed position, rotating around an effective axis of rotation.
- ⁇ l the x-position of the ROI at 0 degrees, converted to stepper motor units.
- ⁇ 2 the x-position of the ROI at 180 degrees, converted to stepper motor units.
- ⁇ w the width of the imaging window, converted to stepper motor units.
- the average ⁇ l and ⁇ 2 provides the position ( ⁇ s) of the axis of rotation of the stepper motor relative to the imaging window ( ⁇ s).
- the x-displacement which would be necessary to centre the axis of rotation of the stepper motor within the imaging window is:
- the ROI can be positioned on the optical axis by movements of the secondary x z stepper motors, in which the total displacements (Xt and Zt) are calculated by:
- the 3-D shape of the region sampled from one OPT reconstruction is substantially a cylinder with a circular cross-section, whose axis of rotational symmetry is the effective axis of rotation used during imaging, and whose diameter and length are described by the width and height of the field-of-view. Since we can alternate between cartesian and polar coordinates to describe positions within the specimen, and can relate the sizes of pixels to real distances within the specimen, we can easily calculate the position and shape of the sampled cylinder relative to any other scans made of the same specimen.
- a high-resolution image is often constructed by taking many high magnification images of small regions of the object, and then joining the smaller images together. This is often known as “tiling” or "patching”.
- the computer-controlled XYZ stage allows the same approach to be applied to 3-D OPT imaging.
- the sampled region from an OPT scan is a cylinder with circular cross-section.
- Figure 14 illustrates, in plan view looking down along the axis 94, how a specimen 160 can be imaged in one scan 162 at low-resolution, or alternatively could be imaged by positioning seven high-resolution scans 170 such that every position within the specimen is contained within at least one sampled region. Since the individual sample regions have a circular cross-section, one efficient arrangement for covering a large region is to arrange the scans in a hexagonal pattern, with slight overlaps between adjacent scans. Different positions along the y-axis of the specimen can also be sampled using the y-axis stepper motor.
- This tiling process can be completely controlled and performed by the computer.
- calculating the position of the optimal sampled region can be done automatically without the need for the user to identify the ROI as previously described.
- Simple image-processing can find the outline or the centre of the specimen within test images during the alignment process, as follows:
- a collimated illumination means which may be used in the rotary stage of Figure 1 or Figure 9, is illustrated in Figures 15 and 16.
- a laser or other light source 172 is used in conjunction with a focussing means (either refractive lenses 174 or reflective mirrors) to generate a beam of light 176 in which all light rays are substantially parallel to the optical axis.
- Figure 15 illustrates this device in relation to the remainder of the rotary stage which, in this example, has two stepper motors 150, 154 for computer-controlled adjustment in the x and z directions rexpectively.
- Vertical adjustment is effected manually by vertical adjuster 40.
- the lens 22 is capable of tilt adjustment about axis 23.
- a wavelength filter 178 is placed at some position between the light source 180 and the specimen 28. This may either consist of a series of different filters, each permitting the transmission of different range of wavelengths, which may be manually or automatically positioned in the lightpath. Or it may be an electronically-tunable filter.
- two electronically-tunable liquid crystal filters may be used for fluorescent imaging to restrict the wavelengths of both the illumination light and the detected light, this possibility being illustrated by the second electrically-controlled filter 182 placed in front of a 2D array of light detectors 184.
- a given chemical will absorb different wavelengths with varying degrees of efficiency. These differences can be represented as a spectrum (which describes the absorption for a large range of wavelengths). Most specimens consist of varying spatial distributions of different chemicals, and consequently different specimens are optimally imaged using different wavelengths (or combinations of wavelengths).
- the described filter system allows the user to alter which wavelengths are used to image a given specimen.
- fluorescent chemicals possess one spectrum which describes the efficiency of different wavelengths to excite them, and a second spectrum which describes the abundance of different wavelengths emitted on fluorescence.
- the use of two electronically-controlled filters produces (at least) a 2-D parameter space for the possible combinations of excitation and emission. Such a system allows the exploration of optimal combinations to distinguish between different chemicals. This allows the 3- D histology of bio-medical samples to be imaged without the need for specific stains.
- Figure 18 illustrates a modification of the arrangement of Figure 15.
- the light emanating from the chamber 26 enters microscope optics and a digital camera, giving a short working distance between the microscope objective 30 and the specimen.
- the specimen may be positioned by the use of a translation stage carried by the shaft 44.
- the translation stage has manual or computer-controlled adjustment in the x and z directions.
- the apparatus and methods can be used in various analyses and procedures, as set out below:
- Analysis of the distribution of transgenic gene activity within biological tissues Analysis of the distribution of cell activities within biological tissues, including:
- S ⁇ '-dibromo ⁇ '-dichloro-indigo fo ⁇ nazan or other coloured precipitates generated through the .catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
- any fluorescent substances such as: Alexa dyes, FITC, rhodamine,
- GFP green fluorescent protein
- amphibians including the genus Xenopus and axolotls
- reptiles birds including chickens and quails
- all mammals including all rodents, dogs, cats and all primates, including human
- embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
- any tissues for the purpose of genomics research including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
- Analysis of any tissue for pharmaceutical research including: the analysis of pharmaceutical substances (such as drags, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the stracture or morphology of tissues.
- pharmaceutical substances such as drags, molecules, proteins, antibodies
- tissues for medical research including: research into the genetics, development, physiology, stracture and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
- Analysis of tissues for medical diagnosis, treatment or monitoring including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal stracture or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Uses of optical projection tomography methods and apparatus in a variety of analyses and procedures is disclosed. The apparatus is a rotary stage (10) which includes a stepper motor (42) with a rotatable vertical shaft (44) the lower end of which carries a specimen (28) to be imaged so that the specimen is rotated about a substantially vertical axis. The stepper motor (42) is mounted on a table (34) the position of which is accurately adjustable in tilt and in vertical position to ensure that the rotational axis of the specimen is perpendicular to the optical axis (29). The specimen (28) rotates within a stationary chamber (26) and the rotary stage is used with a microscope which provides a three-dimensional image of the specimen.
Description
Title: Uses of Optical Projection Tomography Methods and Apparatus
The present invention relates to uses of optical projection tomography methods and apparatus.
Methods and apparatus for optical projection tomography are described in pending International Patent Application PCT/GB02/02373. The foil text of the patent application and the references cited therein are hereby incorporated by reference.
According to the present invention, there is provided a method of performing any one or more of the analyses or procedures listed hereunder comprising use of a method or apparatus of any of the aspects set out below, and as in the earlier patent application.
There is also provided use of a method or apparatus as described in any of the aspects as set out below in any one or more of the analyses or procedures listed hereunder.
According to the present invention, the analyses and procedures of the present invention include:
Analysis of the structure of biological tissues.
Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest
- Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as:
5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins,
And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.)
analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish (including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails) all mammals (including all rodents, dogs, cats and all primates, including human)
Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
Analysis of any tissues for the purpose of genomics research, including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms
the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the structure or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains
Analysis of any tissue for pharmaceutical research, including: the analysis of pharmaceutical substances (such as drugs, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the structure or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, structure and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases
including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
Analysis of tissues for medical diagnosis, treatment or monitoring, including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal structure or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue
the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
According to the present invention, samples for use in the present invention may be prepared as described in the earlier patent application and/or employing conventional pathological and histological techniques and procedures well known to persons skilled in the art.
For example, in-situ hybridisation (particularly useful for detecting RNAs): Hammond K L, Hanson I M, Brown A G, Lettice L A, Hill R E "Mammalian and Drosophila dachsund genes are related to the Ski proto-oncongene and are expressed in eye and limb". Mech Dev. 1998 Jun;74(l-2): 121-31.
Immunohistochemistry (particularly useful for detecting proteins and other molecules): Sharpe J, Ahlgren U, Perry P, Hill B, Ross A, Hecksher-Sorensen J, Baldock R, Davidson D. "Optical projection tomography as a tool for 3D microscopy and gene expression studies" Science. 2002 Apr 19;296(5567):541-5.
It will be appreciated that modification may be made to the invention without departing from the scope of the invention.
In accordance with an aspect of the present invention, there is provided a rotary stage for use in imaging a specimen from a plurality of directions, the rotary stage comprising specimen support means including a rotatable member operative to rotate a specimen to be imaged about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein
the specimen support means is disposed above a stationary imaging chamber for receiving the specimen immersed in optical imaging fluid within the chamber.
The rotary stage may be used with a separate microscope and associated hardware and software that allows three dimensional imaging of a specimen, such as a biological tissue. By having a specimen support means spaced from the microscope, the positioning of the specimen can be easily adjusted due to improved accessibility of the specimen holder. With an elongate specimen, the longest axis of the specimen is substantially parallel to gravity when held within the specimen support means. This allows the specimen to be held at one point only, again assisting with location of the specimen within the specimen support means, and avoids deflection of the specimen through gravitational effects, as such deflection can cause unwanted distortion of the specimen shape and affect the accuracy and resolution of the image obtained.
By having a stationary chamber separated from the rotational part of the stage, the chamber shape is not limited to a rotationally symmetric shape. Preferably the chamber has at least one planar face on which light impinges to image the specimen. Use of a flat planar face with no imperfections or undulations ensures that image distortion due to refraction of light is reduced. The chamber may be formed as a transparent hollow cuboid and arranged such that two opposing sides of the cuboid are substantially perpendicular to the optical axis along which light is emitted from the specimen so that a large cross-sectional area is presented to the optical axis. The selection of such a chamber with a square cross-section ensures that the amount of light refracted before passing through the specimen is substantially reduced over prior art cylindrical rotating chambers and thus image quality is improved. One wall or face of the chamber may be shaped so as to refract light in a desired way, for example to provide a magnifying effect.
The rotary stage may f rther comprise a pivotally mounted adjustment means, such as a lever, having a spigot extending therefrom, the spigot being arranged in use so as to engage with a specimen to alter its position relative to the axis of rotation.
The rotary stage may further comprise a prism positioned so as to receive light after the latter has illuminated the specimen, the prism acting to deflect light through 90° to enable the light to be received by a microscope with a vertical optical axis. By using a prism, the optical path to the microscope does not need to be straight, and thus modification of existing microscopes is not needed for use with a rotary stage in accordance with the present invention.
The rotatable member of the specimen support means may be carried on an adjustable platform, the position of which relative to the horizontal is variable. This allows the axis of rotation to be adjusted relative to an optical axis so that if required a 90° angle is set between the optical axis and the axis of rotation. This is particularly useful for three dimensional imaging.
The adjustable platform is preferably vertically adjustable so as to raise and lower the rotating member relative to the optical axis, so allowing a specimen to be lowered into or out of an optical path of light.
Preferably the rotatable member is formed to enable the specimen to be hung, suspended or to downwardly depend from the lower end of the rotatable member. Where a specimen is appropriately prepared with a magnetisable metal mount, attachment of the specimen to the specimen support means is then straightforward, just relying on magnetic attraction and not on a delicate fixing. This is of advantage as typically the specimens are rather small and delicate, usually with a diameter in the range l-20mm, and securing them in a holder using a screw thread can be complicated.
In accordance with another aspect of the present invention, there is provided a method of obtaining an image of a specimen, the method comprising rotating the specimen about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the rotating specimen is immersed in fluid within a stationary optical chamber.
Brief Description of the Drawings
The invention will now be described, by way of example, with reference to the accompanying drawings in which:
Figures 1 to 18 relate to an aspect of the invention in which:
Figure 1 is a perspective view of optical imaging apparatus comprising a rotary stage in accordance with the present invention together with a microscope;
Figure 2 shows a schematic illustration of how such imaging apparatus is controlled when acquiring digital images;
Figure 3 shows a front perspective view of the apparatus;
Figures 4(a) and 4(b) are schematic diagrams used to illustrate the most appropriate working configuration of the apparatus;
Figures 5(a), 5(b), 5(c) and 5(d) illustrate attachment of a specimen to the specimen support means and alignment of a region of interest;
Figures 6(a), 6(b) and 6(c) are schematic diagrams used to explain resolution of the apparatus;
Figures 7(a) shows a cross-section through a prior art specimen containing tube, with Figures 7(b) and 7(c) showing two specimen chambers as used in the present invention;
Figures 8(a) and 8(b) show a partial plan view along line VIII- VIII of Figure 1 , illustrating use of a pivotally mounted lever to adjust specimen position;
Figure 9 is a perspective view of modified optical imaging apparatus according to the invention,
Figure 10 is a diagram illustrating the apparatus of Figure 9,
Figures 11a, lib, lie, 12a, 12b, 13a, 13b and 14 illustrate positioning and viewing of the specimen image in the apparatus of Figure 9,
Figures 15 and 16 illustrate a collimated illumination means which may be used in the apparatus of Figure 1 or Figure 9,
Figure 17 indicates a way of selecting wavelength from a light source in the optical stage of Figure 1 or Figure 9; and
Figure 18 illustrates a modification of the apparatus shown in Figure 16.
Detailed Description
Figure 1 shows optical imaging apparatus in the form of an OPT scanner comprising a rotary stage 10 and a long working-distance or dissecting microscope 12, separate from the rotary stage 10. The rotary stage 10 has a support 14, a pivotally mounted lever 16, an iris and optical diffoser 20, and a quartz prism 22. The support 14, iris and diffuser 20, and prism 22 are fixed to a base 24 of the stage 10, as is a holder 25 for
receiving a transparent chamber 26, or cuvette, of a generally cuboid shape. The cuvette 26 contains a fluid with suitable optical properties for imaging a specimen 28 suspended within the cuvette, an appropriate fluid being a mixture of benzyl alcohol and benzyl benzoate. This apparatus can be used for brightfϊeld, darkfield and fluorescence imaging but is particularly appropriate where a three dimensional (3D) image of the specimen is created from a series of images taken at different angles, and for specimens too large to be imaged by confocal microscopy.
Light passes along optical axis 29, passing through the centre of the iris arid diffuser 20, and through the specimen 28 and is deflected through right angles by the prism 22 to enter an objective 30 of the microscope 12. As the microscope has a large working distance, enough space is available for the prism 22 to rest beneath the microscope objective 30. Using a prism allows a vertically oriented microscope to image the specimen. However the prism 22 can be omitted where the microscope objective is parallel to the optical axis. The iris and diffuser 20 control the amount of light passing from a light source (not shown) to reach the specimen 28 and provide even illumination.
The support 14 carries a circular boss on which is pivotally mounted, about an axis 90 (Figure 4), a tilting plate 33 upon which is slidable, upwards and downwards, a plate 32. The plate 32 carries an adjustable platform 34 cantilevered horizontally from the plate 32. The angle of the platform 34 can be altered relative to the horizontal using a tilt adjuster 36 and the vertical position of the platform 34 can be varied by means of a vertical adjuster 40. A stepper motor 42 is mounted on the platform 34, with a rotatable motor shaft 44 of the motor extending through the platform 34. A magnet 46 (a permanent magnet or an electro-magnet) is attached to the lower end of the shaft 44 and carries the specimen 28 to be imaged. The manner in which the specimen is attached to the magnet will be described later with reference to Figure 5. The stepper motor 42 rotates the shaft 44 with a step size of 0.9 degrees, providing up to 400 imaging positions of the specimen. A series of digital images of the elongate specimen
28 is taken by indexing the shaft 44 to its successive rotational positions, and thus positioning the specimen in successive rotational positions whilst the specimen is suspended within the cuvette 26, the cuvette remaining stationary.
By mounting the stepper motor 42 with its axis of rotation vertical, the rod-like specimen 28 only needs to be secured at one point, typically its uppermost end, for controlled rotation of the specimen to occur. The specimen 28 is immersed in the liquid, supported from above by the magnet 46, by using the vertical adjuster 40 to lower the platform. This vertical orientation of the specimen and the rotational axis avoids the use of O-rings or other mechanical arrangements which would be necessary to connect the dry motor to the immersed specimen, and secondly it ensures that the specimen is not deflected off its axis of rotation by gravity as the elongate specimen has its major axis parallel to the force of gravity. Avoiding distortion effects to the specimen by having a vertically orientated specimen is particularly important for obtaining accurate 3D images, particularly for larger specimens. Use of a generally upright hollow cuboid as the imaging chamber 26 around the specimen 28 ensures that the surface area of the imaging liquid is limited, reducing evaporation of the liquid. In addition much larger specimens, typically l-20mm in diameter, can be imaged by using such a fixed chamber without loss of digital signal quality.
In use, a digital camera 52 (Figure 2) is attached to the microscope 12 and produces a digital image of the specimen as imaged by the microscope from light that has travelled along the optical axis 29, and been transmitted through the chamber and specimen. A series of digital images are taken of the specimen from different angles and this digital information is fed into an algorithm which uses a mathematical formula to reconstruct the structure of the specimen in three dimensions. Typically the images are obtained using the control elements as set out in Figure 2. Thus a computer 50 carrying digital image acquisition software is in two-way communication with the digital camera 52 attached to the microscope 12 which receives images from a specimen of interest. The computer 50 controls filter wheels 56 attached to the microscope 12 to alter the
wavelength of radiation that is detected. The computer acquisition software is shown diagrammatically in Figure 2 as software 58 to control image-capture from the digital camera, a program 54 to control the imaging software, the rotary stage and the filter wheel software, software 48 to control the filter wheels and software 64 to convert the image files into a 3D reconstruction. The computer is also in two-way communication with electronic control circuits 60 connected to the rotary stage 10 and controls the circuits 60 to adjust the orientation of the specimen as required during image capture of successive images. Once the digital images have been obtained, they are processed at 64 to produce a 3D reconstruction 66 of the specimen using mathematical processing, in a similar manner to the analysis described in US 5,680,484.
If required, the computer can control the entire imaging process, undertaking image- processing to determine the size of the specimen, its alignment, whether it is in focus etc., and adjusting the specimen position before performing the rotational imaging. This complete automation of the imaging process is particularly desirable for large scale gene expression mapping projects in which many such devices could be ran in parallel.
The circuitry 60 responsive to the computer to control the stepper motor 42 is commercially available for most popular computer systems. The circuitry 60 connects to the computer 50 and is responsive to signals from the computer 50 to control a variety of mechanical devices (stepper motors, solenoids etc.).
To create a 3D representation of the specimen, software performs the following functions: (1) determine the axis of rotation (through the symmetry which exists between each pair of images which were taken at 180 degrees to each other), (2) reorganise the stack of images into an orthogonal stack of projection images (in which image represents a single section through the specimen, viewed from all the different angles captured), (3) perform the mathematical processing on each projection image, to recreate that section through the specimen, (4) combine all the calculated section
images into a 3D format. Reconstructions can be created both from transmitted light and from fluorescently-emitted light.
Now that the general apparatus and its use in data acquisition has been described, certain components of the imaging apparatus will be described in more detail.
A front view of the rotary stage 10 is shown in Figure 3. The tilt adjuster 36 varies the angle of tilt of the platform 34 about the axis 90 which is below the lower end of the shaft 44 and is approximately at the height of the specimen so that tilt adjustment does not move the specimen substantially. The axis 90 may intersect the optical axis 29. Tilt adjustment (illustrated- by the double-headed arrow 92 in Figure 3) ensures that the rotational axis 94 of the stepper motor 42 is accurately perpendicular to the optical axis 29. Having adjusted the tilt of the platform 34, the position of the platform 34 relative to the base 24 is adjusted using the vertical adjuster 40 which uses a rack and pinion arrangement to raise and lower the platform 34 in the adjusted direction of the rotational axis 94. By using the vertical adjuster 40, a specimen carried on the magnet attached to the end of the shaft 44 can be lowered a required depth into the imaging chamber for imaging and raised out of the chamber once imaging has been performed. The vertical position of the specimen during imaging an also be altered in this way if required. In the raised position of the shaft, specimens can be loaded into or out of the rotary stage.
When the apparatus is set up, it is aligned such that the optical axis of the microscope passes through the prism, and through the centre of the imaging chamber. However, at high magnification the alignment can need adjusting as the specimen becomes slightly displaced away from the centre of the field-of-view. The raising/lowering mechanism mentioned above can be adjusted to correct for this misalignment in the vertical direction.
Whilst much imaging of the specimen can be undertaken by having the rotational axis approximately perpendicular to the optical axis, 3D reconstruction of the specimen using the mathematical processing will be of very poor quality unless the angle between the optical axis and the rotational axis is exactly 90°. The tilt adjuster 36 allows the axis of rotation 94 to be tilted slightly so as to ensure the angle is exactly 90°. The tilt adjuster 36 typically relies upon a screw-thread mechanism to urge the platform 34 to one side. A calibration sample is used to adjust the angle of tilt, with the calibration sample containing a number of small particles whose trajectories can be monitored on a computer screen while the shaft rotates. If the axis of rotation is not perfectly perpendicular to the optical axis, the trajectory of the particle appears as an ellipse, see Figure 4(a) which shows the view along the optical axis as the shaft rotates about the axis 94. When the axis is correctly aligned, the particle is seen to move from side to side, with no vertical component to the motion, see Figure 4(b).
Figure 5 shows the magnetic mounting system used which relies upon magnetic attraction between a metal disc 110 attached to a specimen 112 and the cylindrical magnet 46 permanently attached to the lower end of the rotatable shaft 44 of the stepper motor 42. Each specimen has a small magnetisable metal disc glued at one end during specimen preparation. The disc is then attached to the magnet when imaging is to be undertaken and the specimen supported as a result of the magnetic attraction between the disc and the magnet. As the disc 110 and specimen 112 are relatively light, the magnet does not need to be strongly magnetised to support their weight. One advantage of the magnet system over, for example, a screw-in system, is that the small size of the disc and specimen necessitates handling with forceps or tweezers. Placing the mount or disc 110 onto a magnet is straightforward with forceps, whereas screwing it into an attachment is not. Another advantage is that the position of the specimen relative to the axis of rotation can be readily adjusted by sliding the mount 110 across the magnet surface 120. Also many specimens can be pre-prepared with a disc attached, and then quickly fitted into the device for imaging when required.
Certain liquids used in the chamber for sample imaging are toxic and corrosive to plastic, and where this is the case, the specimens are best handled using forceps. The magnetic attachment system is then of advantage as the specimens need only be held under the magnet to become securely attached. It is equally easy to remove each specimen after imaging.
To maximise the resolution of the images, a region of interest 122 in a specimen 112 must be centred on the axis of rotation 94, i.e. not move as the shaft rotates. If the region of interest, or the whole specimen, is off-centre and oscillates from side-to-side during a rotational image capture, then the magnification necessary to keep it in view will be low. This is illustrated in Figure 6(a). The two shapes 130, 132 represent the specimen 112 during rotation, at its most extreme positions to the left and right. When the specimen 112 is perfectly centred, it spins on its own axis, see Figure 6(b). This presents a smaller width across the field-of-view, and so the magnification can be increased to provide an image with higher resolution, see Figure 6(c).
Adjustment of the specimen 112 relative to the axis of rotation 94 is simplified by the magnetic attachment. By pushing on the disc 110, the centre of the disc can be offset relative to the rotational axis 94. In Figure 5(a) the region of interest 122 within the specimen 112 is not centred on the axis of rotation but rather is displaced to the left. If the motor shaft is rotated through 180°, the region of interest 122 is now visible on the right hand side of the axis of rotation, see Figure 5(b). Because the magnet 46 allows the metal mount 110 to slide along it in any direction, without becoming unattached, a push from the side by the lever 16 (indicated by arrow 114 in Figure 5(c) is able to position the specimen so that the region of interest 122 is centred on the axis of rotation, see Figure 5(c). A further rotation of 180° shows that now the whole specimen 112 oscillates from side-to-side while the region of interest remains centred, see Figure 5(d). Adjustment of the specimen in this way is usually undertaken whilst observing images of the rotating specimen on a computer screen.
The imaging chamber 26 as shown in Figure 1 will now be described in more detail with reference to Figure 7. By having a fixed specimen chamber that does not rotate with the specimen during imaging, the chamber does not need to be cylindrical to maintain a constant optical path during rotation, as for the system described in US 5,680,484. A comparison of prior art tube 136 and the chamber used in the present invention is shown in Figure 7, Figure 7(a) showing a cross-section through the prior art cylindrical tube 136 (which is suspended horizontally), and Figure 7(b) showing the chamber 26 used in the present embodiment. The imaging chamber 26 is chosen to be generally cuboid and to be square in cross-sectional shape, and is made from quartz, glass or other suitably transparent material. Each chamber /tube contains a specimen 141 bathed in liquid 143 with suitable optical properties to allow imaging of the specimen. The flat sides 142, 142' 144, 144' of chamber 26 reduce refractive distortion of the image and allow larger specimens to be imaged. This is because the mutually parallel walls 142, 142' of the square cross-section chamber are aligned perpendicular to the optical axis 29 and provide a greater imaging area over which non- refraction of light occurs than for the circular tube 136, which only has a very small part of its circumference at normal incidence to the light. Thus a good image can be formed across a width of more than 10mm for the chamber 26, improving the amount of signal received from the sample and reducing distortion due to refraction.
Figure 7c illustrates a modification of the sample chamber of Figure 7b. In Figure 7c, the sample chamber 26' has a square internal cross-section but one wall 140 is shaped to provide a plano-convex lens to refract light leaving the chamber. The shaping causes a desired refraction, in the case of Figure 7c a magnifying effect.
The lever 16 shown in Figure 1 is now described in more detail with reference to Figure 8, which shows a plan view along line VIII- VIII of Figure 1. Figure 8(a) shows the lever 16 in its usual position, pushed away from the magnet 46 and metal specimen mount 110. If the specimen is displaced too far to one side (as illustrated) the lever 16 can be moved about pivot 164 so that spigot 166 engages with metal mount 110 to push
the specimen into the correct position (Figure 8b). This is done while the specimen position is monitored on the computer screen. Since the stepper motor can be carefully controlled through manual switches, the specimen trajectory during rotation can be observed and the motor stopped when the specimen is maximally to one side. The specimen is then centred using the lever 16, and the process repeated until alignment of the specimen relative to the optical axis is complete. The lever 16 is organised so as to produce a "geared-down" movement to the specimen, which makes it easier to control the adjustment.
The pivot 164 is attached to the main motor stage. It is fixed to the stage by a support which ensures the spigot 166 is at the correct height to contact the metal mount, just below the magnet. This way, the spigot 166 remains at the correct height irrespective of the height chosen to image the specimen.
The apparatus described herein is suitable for 3D microscopy and also rotational microscopy for any purpose, on biological specimens and specimens from other fields such as' material science.
When undertaking 3D microscopy, the refractive index should be uniform throughout the specimen. For biological tissue this is easily achieved by bathing the specimen in a clearing solvent. A specimen can be glued directly onto the metal mount, or embedded in a block of transparent matrix such as agarose, which is itself adhered to the mount. The clearing solvent then permeates the blocks as well as the specimen. BABB (a mixture of benzyl alcohol and benzyl benzoate) is suitable as a solvent.
For a specimen whose refractive index cannot be made uniform, or which is not transparent, the technique is still of use. The 3D surface shape of objects whose cross- sections are all convex (even if the whole 3D shape is not convex) can accurately be recreated from its rotating silhouette.
There are some applications where the raw data of the apparatus is useful. The series of images can be converted into a movie of the rotating object (i.e. the specimen). It is much easier to grasp the shape of a 3D object when it is viewed rotating than from a few static 2D images (many 3D reconstruction projects present their results as movies of a model rotating).
The apparatus is also suitable for undertaking 3D mapping of gene expression patterns (RNA and/or protein distribution) in biological tissue, whilst allowing the specimen to be used for other analysis after imaging. Specimen imaging using the apparatus is relatively quick, taking around 20 minutes. In contrast preparing, embedding, sectioning, mounting, staining and digitising real histological sections takes days and produces hundreds of digital 2D sections, but no guaranteed way to align them with each other to recreate the original 3D shape. The histological sections tend to stretch significantly, such that even if all the sections can be fitted onto each other to create a 3D shape, the final result will not accurately reflect the shape of the original specimen. However the results obtained using the apparatus are very similar to the real physical shape of the specimen, the only difference from physical sections being reduced resolution. As the data generated by the apparatus is genuinely 3D it can be virtually resectioned in any orientation, or rendered in 3D.
A modified construction of rotary stage is illustrated in Figure 9 where parts corresponding to those of Figure 1 bear the same reference numerals. In the rotary stage of Figure 9, three-dimensional adjustment of the position of the stepper motor 42 is achieved by the use of three secondary stepper motors 150, 152, 154. No tilt adjuster for the motor 42 is present. Instead, the prism is capable of being manually adjusted by controlled tilting about a transverse horizontal axis 23. The important stepper motors are the motors 150 and 154. The motor 152 can be replaced by a manual vertical adjuster 40.
The secondary stepper motors 150, 152, 154 allow sub-micron accuracy adjustment of the 3D position of the primary stepper motor 42, along the orientations labelled as x, y and z. These stepper motors 150, 152, 154 are controlled by the same computer which controls the primary motor 42. This is illustrated in Figure 10 where the computer 50 drives the four motors through motor driving circuits 156. For the purposes of this document, the z-axis is considered parallel to the optical axis 29. Movements along this axis effectively alter the focus of the system. Movements along the other two axes alter which part of the specimen coincides with the centre of the optical axis 29.
The computer-controlled translation by the three secondary motors 150, 152, 154 has the following advantages:
1) It allows the region of interest (ROI) of the specimen to be maintained centrally within the field-of-view of the microscope. This is achieved in two ways:
(a) The ROI is maintained within the depth-of-focus of the microscope.
(b) It limits the "side-to-side" oscillatory movements of the ROI along the x- axis.
These two advantages allow much higher resolution imaging as compared to a system which has no such mechanism.
2) It is more accurate than the lever and spigot system of Figures 1 and 8.
3) It can be controlled completely by the computer (unlike the lever and spigot system), so the ROI can be easily defined "on-screen" within the software.
4) It allows the computer to calculate precise 3D coordinates for the ROI.
5) It allows different scans within the same specimen to be related to each other in 3D space.
6) This allows the computer to build-up a high resolution scan of a large specimen from multiple automatic scans of smaller regions at higher magnification (known as "tiling" or "patching").
Computer controlled x and z movements to maintain the ROI within the field-of-view are calculated as follows:
First, the software needs to calculate the positions of:
(a) The axis of rotation of the primary stepper motor 42 relative to the field- of-view.
(b) The ROI relative to the axis of rotation of the primary stepper.
These two positions can be calculated from one operation. The magnification is set low enough such that during a full rotation the ROI stays within the field-of-view of the camera. The system is previously calibrated such that it is known how many pulses to the x-stepper motor correspond to a given displacement as measured in pixels on the computer screen. This relationship is determined for each magnification. The computer then presents the user with four images of the specimen, rotated to 0, 90, 180 and 270 degrees (as seen in Figures 11a to lie). In Figure 11a, each outer rectangle represents the imaging window on the computer screen and the spot represents the region of interest 122 of the specimen.
Figure 1 lb shows views along the optical axis (as seen on the computer screen) for low magnification, and Figure l ie shows plan views along the axis of rotation 94. The user then uses the computer mouse (or equivalent) to indicate where the ROI is in each image.
Figure 12 shows how the positioning system can move the stepper motor 42 in both the x and z dimensions, and can therefore compensate for the ROI being off-centre. The x and z movements of the motor 42 are controlled by the computer to ensure that the ROI 122 remains in a fixed position, rotating around an effective axis of rotation.
In Figures 11a, lib and lie:
χl = the x-position of the ROI at 0 degrees, converted to stepper motor units. χ2 = the x-position of the ROI at 180 degrees, converted to stepper motor units. χw = the width of the imaging window, converted to stepper motor units.
The average χl and χ2 provides the position (χs) of the axis of rotation of the stepper motor relative to the imaging window (χs). The average of Zl and Z2 provides a second estimate of this position (χs = (χl+ χ2+Zl+Z2)/4). The x-displacement which would be necessary to centre the axis of rotation of the stepper motor within the imaging window is:
X-displacement (χd) = χw/2 - (χl+ χ2+Zl+Z2)/4
This is illustrated in Figures 13a and 13b.
In Figures 13a and 13b, the microscope views the specimen from the bottom of the diagram. The edges of the field-of-view therefore appear as two substantially parallel lines, which indicate the limits of what can be seen. The optical axis, which is the centre of this field-of-view, is shown as a vertical dashed line in Figure 13 a.
Figure 13b shows the specimen at a rotational position of 0 degrees (α=0). From the measurements described on the previous page (χl, χ2, Zl, Z2) the x and z distances of the ROI from the axis of rotation of the primary stepper motor can easily be calculated, χαo
is the x-distance when the rotational position (angle α) is zero (χαo= ( χl - χ2)/2). Similarly, Zαo can be calculated from the two measurements taken at α=90 degree and =270 degrees, (Zαo=(Zl-Z2)/2). The position of the ROI can then be converted from cartesian coordinates to polar coordinates where D is the distance of the ROI from the stepper motor axis, and θ is the angle of that line to the optical axis (or a line parallel to it), when α = 0 degrees.
D = square root of (χαo2+Zαo2) θ = tan"1 (χ o/Zαo)
Now, for any rotational position of the primary stepper motor (α) the ROI can be positioned on the optical axis by movements of the secondary x z stepper motors, in which the total displacements (Xt and Zt) are calculated by:
χt = χ d + Z).sin (α + θ), and Zt = D.cos (α + θ).
The 3-D shape of the region sampled from one OPT reconstruction is substantially a cylinder with a circular cross-section, whose axis of rotational symmetry is the effective axis of rotation used during imaging, and whose diameter and length are described by the width and height of the field-of-view. Since we can alternate between cartesian and polar coordinates to describe positions within the specimen, and can relate the sizes of pixels to real distances within the specimen, we can easily calculate the position and shape of the sampled cylinder relative to any other scans made of the same specimen.
In 2-D imaging, a high-resolution image is often constructed by taking many high magnification images of small regions of the object, and then joining the smaller images together. This is often known as "tiling" or "patching". The computer-controlled XYZ stage allows the same approach to be applied to 3-D OPT imaging.
As described above, the sampled region from an OPT scan is a cylinder with circular cross-section. Figure 14 illustrates, in plan view looking down along the axis 94, how a specimen 160 can be imaged in one scan 162 at low-resolution, or alternatively could be
imaged by positioning seven high-resolution scans 170 such that every position within the specimen is contained within at least one sampled region. Since the individual sample regions have a circular cross-section, one efficient arrangement for covering a large region is to arrange the scans in a hexagonal pattern, with slight overlaps between adjacent scans. Different positions along the y-axis of the specimen can also be sampled using the y-axis stepper motor.
This tiling process can be completely controlled and performed by the computer.
For all specimens which are to be imaged in their entirety with one scan, calculating the position of the optimal sampled region can be done automatically without the need for the user to identify the ROI as previously described. Simple image-processing can find the outline or the centre of the specimen within test images during the alignment process, as follows:
1) Set magnification to low (can be done automatically using a computer- controlled microscope).
2) Take four images at 0, 90, 180 and 270 degrees rotation.
3) Calculate, a histogram of each image to determine a suitable threshold level to distinguish the specimen from the background.
4) Calculate the position of the centre-of-mass of the specimen in each image.
5) Use these positions as the ROI measurements as previously described.
6) Apply the new displacements during any subsequent rotations.
7) Increase magnification.
8) Take four rotated images and determine whether magnification is too high (i.e. if edges of specimen are outside of the field-of-view).
9) If specimen still within field-of-view go back to step 4.
10) If edges of specimen are outside field-of-view reduce magnification to previous value.
11) Scan specimen.
A collimated illumination means, which may be used in the rotary stage of Figure 1 or Figure 9, is illustrated in Figures 15 and 16.
A laser or other light source 172 is used in conjunction with a focussing means (either refractive lenses 174 or reflective mirrors) to generate a beam of light 176 in which all light rays are substantially parallel to the optical axis. Figure 15 illustrates this device in relation to the remainder of the rotary stage which, in this example, has two stepper motors 150, 154 for computer-controlled adjustment in the x and z directions rexpectively. Vertical adjustment is effected manually by vertical adjuster 40. The lens 22 is capable of tilt adjustment about axis 23.
As a result of experiments it is clear that illuminating light which enters the specimen non-parallel to the optical axis introduces noise into the results. A collimated light source, where, all illuminating light rays are parallel to the optical axis, reduces this problem and therefore increases the quality of imaging.
Referring to Figure 17, a wavelength filter 178 is placed at some position between the light source 180 and the specimen 28. This may either consist of a series of different
filters, each permitting the transmission of different range of wavelengths, which may be manually or automatically positioned in the lightpath. Or it may be an electronically-tunable filter.
Alternatively, two electronically-tunable liquid crystal filters may be used for fluorescent imaging to restrict the wavelengths of both the illumination light and the detected light, this possibility being illustrated by the second electrically-controlled filter 182 placed in front of a 2D array of light detectors 184.
A given chemical will absorb different wavelengths with varying degrees of efficiency. These differences can be represented as a spectrum (which describes the absorption for a large range of wavelengths). Most specimens consist of varying spatial distributions of different chemicals, and consequently different specimens are optimally imaged using different wavelengths (or combinations of wavelengths). The described filter system allows the user to alter which wavelengths are used to image a given specimen.
Similarly, fluorescent chemicals possess one spectrum which describes the efficiency of different wavelengths to excite them, and a second spectrum which describes the abundance of different wavelengths emitted on fluorescence. The use of two electronically-controlled filters produces (at least) a 2-D parameter space for the possible combinations of excitation and emission. Such a system allows the exploration of optimal combinations to distinguish between different chemicals. This allows the 3- D histology of bio-medical samples to be imaged without the need for specific stains.
It will be appreciated that a rotary stage according to the invention need not include a prism 22, and nor need the rotary stage be used with a standard vertical microscope. Figure 18 illustrates a modification of the arrangement of Figure 15. In Figure 18 (where parts corresponding to those of Figure 15 bear the same reference numerals), the light emanating from the chamber 26 enters microscope optics and a digital camera, giving a short working distance between the microscope objective 30 and the specimen.
The specimen may be positioned by the use of a translation stage carried by the shaft 44. The translation stage has manual or computer-controlled adjustment in the x and z directions.
The apparatus and methods can be used in various analyses and procedures, as set out below:
Analysis of the structure of biological tissues.
Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest
- Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as:
S^'-dibromo^^'-dichloro-indigo (or other halogenated indigo compounds)
foπnazan or other coloured precipitates generated through the .catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins,
And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.) analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish
(including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails)
all mammals (including all rodents, dogs, cats and all primates, including human)
Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
Analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains
Analysis of any tissue for pharmaceutical research,
including: the analysis of pharmaceutical substances (such as drags, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the stracture or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, stracture and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
Analysis of tissues for medical diagnosis, treatment or monitoring, including:
the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal stracture or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
It will be appreciated that modification may be made to the invention without departing from the scope of the invention.
Claims
1. A method of performing any one or more of the analyses or procedures listed hereunder, the method comprising use of a rotary stage comprising specimen support means including a rotatable member operative to rotate a specimen to be imaged about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the specimen support means is disposed above a stationary imaging chamber for receiving the specimen immersed in optical imaging fluid within the chamber:
Analysis of the structure of biological tissues.
Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest
- Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as: 5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins,
And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.) analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish (including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails) all mammals (including all rodents, dogs, cats and all primates, including human)
Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
Analysis of any tissues for the purpose of genomics research, including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains Analysis of any tissue for pharmaceutical research, including: the analysis of pharmaceutical substances (such as drags, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the stracture or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, stracture and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases Analysis of tissues for medical diagnosis, treatment or monitoring, including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal structure or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
2. A method of performing any one or more of the analyses or procedures listed hereunder, the method comprising use of a method of obtaining an image of a specimen, the method comprising rotating the specimen about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the rotating specimen is immersed in fluid within a stationary optical chamber:
Analysis of the structure of biological tissues. Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest
- Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as:
5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins, And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.) analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish (including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails) all mammals (including all rodents, dogs, cats and all primates, including human)
Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations) Analysis of any tissues for the purpose of genomics research, including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains
Analysis of any tissue for pharmaceutical research, including: the analysis of pharmaceutical substances (such as drags, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the stracture or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, stracture and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
Analysis of tissues for medical diagnosis, treatment or monitoring, including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal structure or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
3. Use of a rotary stage comprising specimen support means including a rotatable member operative to rotate a specimen to be imaged about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the specimen support means is disposed above a stationary imaging chamber for receiving the specimen immersed in optical imaging fluid within the chamber, in any one or more of the analyses or procedures listed hereunder:
Analysis of the structure of biological tissues.
Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest - Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as:
5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins,
And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.) analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish (including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails) all mammals (including all rodents, dogs, cats and all primates, including human)
Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
Analysis of any tissues for the purpose of genomics research, including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains
Analysis of any tissue for pharmaceutical research, including: the analysis of pharmaceutical substances (such as drugs, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the stracture or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, structure and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drag-related iatrogenic or idiopathic diseases
Analysis of tissues for medical diagnosis, treatment or monitoring, including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal stracture or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
4. Use of a method of obtaining an image of a specimen, the method comprising rotating the specimen about a vertical or substantially vertical axis of rotation transverse to an optical axis along which light is emitted from the specimen, wherein the rotating specimen is immersed in fluid within a stationary optical chamber, in any one or more of the analyses or procedures listed hereunder:
Analysis of the stracture of biological tissues.
Analysis of the function of biological tissues.
Analysis of the shapes of biological tissues.
Analysis of the distribution of cell types within biological tissues.
Analysis of the distribution of gene activity within biological tissues, including the distribution of:
- RNA transcripts
- proteins
Analysis of the distribution of transgenic gene activity within biological tissues, Analysis of the distribution of cell activities within biological tissues, including:
- Cell cycle status including arrest
- Cell death
- Cell proliferation
- Cell migration
Analysis of the distribution of physiological states within biological tissues. Analysis of the results of immunohistochemistry staining techniques. Analysis of the results of in-situ hybridisation staining techniques. Analysis of the distribution of molecular markers within biological tissues, including any coloured or light-absorbing substances, such as:
5,5'-dibromo-4,4'-dichloro-indigo (or other halogenated indigo compounds) formazan or other coloured precipitates generated through the catalytic activity of enzymes including: b-galactosidase, alkaline phosphatase or other coloured precipitates formed upon catalytic conversion of staining substrates, including: Fast Red, Vector Red
And including any light-emitting substances,
Therefore including any fluorescent substances, such as: Alexa dyes, FITC, rhodamine,
And including any luminescent substances, such as green fluorescent protein (GFP) or similar proteins,
And including any phosphorescent substances.
Analysis of tissues from all plant species. Analysis of any tissue for agricultural research, including: basic research into all aspects of plant biology (genetics, development, physiology, pathology etc.) analysis of tissues which have been genetically altered.
Analysis of tissues from all animal species, including: invertebrates nematode worms vertebrates all types of fish (including teleosts, such as zebrafish, and chondrycthes including sharks) amphibians (including the genus Xenopus and axolotls) reptiles birds (including chickens and quails) all mammals (including all rodents, dogs, cats and all primates, including human) Analysis of embryonic tissues for any purpose, including: research into any stem cell population research into developmental biology research into the causes of abnormal embryo development, including human syndromes autopsies of human terminated pregnancies (both spontaneous and induced terminations)
Analysis of any tissues for the purpose of genomics research, including: the analysis of any tissues for the purpose of genomics research, including: the analysis of transgenic, knock-in, knock-down or knock-out organisms the analysis or discovery of the expression (or activity) of genes including their spatial distribution, and their levels of expression the analysis of discovery of abnormalities in the stracture or morphology of tissues, as a result of interference due to wilful experimentation (such as genetic or physical modifications including a chemical or biochemical genomics approach), and/or spontaneous abnormalities (such as naturally-occurring mutations)
Analysis of any tissue for the purpose of neurobiology research, including: the analysis of the morphology of nerves the analysis of the pathways and connectivity of nerves the analysis of parts of, or whole, animal brains
Analysis of any tissue for pharmaceutical research, including: the analysis of pharmaceutical substances (such as drags, molecules, proteins, antibodies), including their spatial distribution within the tissue, and their concentrations the analysis or discovery of abnormalities in the structure or morphology of tissues.
Analysis of tissues for medical research, including: research into the genetics, development, physiology, stracture and function of animal tissues analysis of diseased tissue to further our understanding of all types of diseases including: congenital diseases acquired diseases including: infectious neoplastic vascular inflammatory traumatic metabolic endocrine degenerative drug-related iatrogenic or idiopathic diseases
Analysis of tissues for medical diagnosis, treatment or monitoring, including: the diagnosis of cancer patients including: searching for cancerous cells and tissues within biopsies searching for abnormal stracture or morphology of tissues within biopsies the analysis of all biopsies including the analysis of: lymph nodes polyps liver biopsies kidney biopsies prostate biopsies muscle biopsies brain tissue the analysis of tissue removed in the process of extracting a tumour from a patient including: determining whether all the tumour has been removed determining the type of tumour, and the type of cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2003285523A AU2003285523A1 (en) | 2002-11-27 | 2003-11-26 | Uses of optical projection tomography methods and apparatus |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0227649.1 | 2002-11-27 | ||
| GBGB0227649.1A GB0227649D0 (en) | 2002-11-27 | 2002-11-27 | Uses of optical projection tomography methods and apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004048970A1 true WO2004048970A1 (en) | 2004-06-10 |
Family
ID=9948602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2003/005143 WO2004048970A1 (en) | 2002-11-27 | 2003-11-26 | Uses of optical projection tomography methods and apparatus |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003285523A1 (en) |
| GB (1) | GB0227649D0 (en) |
| WO (1) | WO2004048970A1 (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008010759A1 (en) | 2006-07-19 | 2008-01-24 | Hemocue Ab | Apparatus for capturing an image |
| WO2007089641A3 (en) * | 2006-01-26 | 2008-02-21 | Univ Texas | Process and apparatus for imaging |
| GB2442290A (en) * | 2006-06-01 | 2008-04-02 | Ana Tec As | Rotating object image analysis |
| WO2008131840A2 (en) * | 2007-04-26 | 2008-11-06 | Carl Zeiss Microimaging Gmbh | Sample holder for a microscope |
| WO2009030966A1 (en) * | 2007-09-03 | 2009-03-12 | Szegedi Tudományegyetem | Optical microscope system and method carried out therewith for reconstructing an image of an object |
| WO2011124317A1 (en) * | 2010-03-30 | 2011-10-13 | Technische Universität Wien | Histological method |
| CN102389291A (en) * | 2011-06-09 | 2012-03-28 | 广西中医学院 | Experimental animal sign information collection and analysis system and collection and analysis method |
| WO2012146720A1 (en) * | 2011-04-29 | 2012-11-01 | Peira Bvba | Stereo-vision system |
| DE102013210269B3 (en) * | 2013-06-03 | 2014-11-06 | Laser Zentrum Hannover E.V. | Apparatus and method for assaying samples in a liquid |
| CN105579828A (en) * | 2013-05-28 | 2016-05-11 | 克莫麦特公司 | Image forming cytometer |
| WO2019020975A1 (en) * | 2017-07-24 | 2019-01-31 | University College Cardiff Consultants Ltd | Analysing nano-objects |
| EP3485976A1 (en) * | 2017-11-21 | 2019-05-22 | Koninklijke Philips N.V. | Method of handling a biopsy sample |
| CN110673323A (en) * | 2019-10-16 | 2020-01-10 | 西湖大学 | Microscope assembly |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4834019A (en) * | 1986-11-27 | 1989-05-30 | Shandon Scientific Limited | Tissue specimen treatment apparatus |
| US5680484A (en) * | 1992-06-09 | 1997-10-21 | Olympus Optical Co., Ltd. | Optical image reconstructing apparatus capable of reconstructing optical three-dimensional image having excellent resolution and S/N ratio |
| US5710625A (en) * | 1996-04-30 | 1998-01-20 | Hughes Electronics | Spectral oil immersion cell |
| WO2002095476A2 (en) * | 2001-05-22 | 2002-11-28 | Medical Research Council | Rotary stage for imaging a specimen |
| WO2004003129A2 (en) * | 2002-06-27 | 2004-01-08 | Medical Research Council | Treatment of tissue specimens |
-
2002
- 2002-11-27 GB GBGB0227649.1A patent/GB0227649D0/en not_active Ceased
-
2003
- 2003-11-26 AU AU2003285523A patent/AU2003285523A1/en not_active Abandoned
- 2003-11-26 WO PCT/GB2003/005143 patent/WO2004048970A1/en not_active Application Discontinuation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4834019A (en) * | 1986-11-27 | 1989-05-30 | Shandon Scientific Limited | Tissue specimen treatment apparatus |
| US5680484A (en) * | 1992-06-09 | 1997-10-21 | Olympus Optical Co., Ltd. | Optical image reconstructing apparatus capable of reconstructing optical three-dimensional image having excellent resolution and S/N ratio |
| US5710625A (en) * | 1996-04-30 | 1998-01-20 | Hughes Electronics | Spectral oil immersion cell |
| WO2002095476A2 (en) * | 2001-05-22 | 2002-11-28 | Medical Research Council | Rotary stage for imaging a specimen |
| WO2004003129A2 (en) * | 2002-06-27 | 2004-01-08 | Medical Research Council | Treatment of tissue specimens |
Non-Patent Citations (4)
| Title |
|---|
| KENG WEE TEIK., SHARPE J., FITZPATRICK D. R.: "Optical Projection Tomographic Examination of Miscarried Human Embryos", JOURNAL OF MEDICAL GENETICS (BRITISH HUMAM GENETICS CONFERENCE. YORK, ENGLAND, UK. SEPTEMBER 23-25), vol. 39, no. supplement 1, September 2002 (2002-09-01), ISSN 0022-2593, pages s23, XP009021392 * |
| SHARPE J ET AL: "OPTICAL PROJECTION TOMOGRAPHY AS A TOOL FOR 3D MICROSCOPY AND GENE EXPRESSION STUDIES", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 296, 19 April 2002 (2002-04-19), pages 541 - 545, XP001152115, ISSN: 0036-8075 * |
| SHARPE J: "Optical projection tomography as a new tool for studying embryo anatomy", JOURNAL OF ANATOMY, CAMBRIDGE UNIVERSITY PRESS, CAMBRIDGE,, GB, vol. 202, no. 2, 1 February 2003 (2003-02-01), pages 175 - 181, XP002262076, ISSN: 0021-8782 * |
| SHARPE JAMES: "OPT microscopy: A new approach for 3D microscopy and gene expression studies", FASEB JOURNAL, vol. 16, no. 5, 22 March 2002 (2002-03-22), Annual Meeting of Professional Research Scientists on Experimental Biology;New Orleans, Louisiana, USA; April 20-24, 2002, pages A1092, XP009021394, ISSN: 0892-6638 * |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007089641A3 (en) * | 2006-01-26 | 2008-02-21 | Univ Texas | Process and apparatus for imaging |
| US8553836B2 (en) | 2006-01-26 | 2013-10-08 | The Board Of Regents, The University Of Texas System | Process for producing a microCT image of a stained specimen |
| US8189737B2 (en) | 2006-01-26 | 2012-05-29 | The Board Of Regents, The University Of Texas System, A Texas Institution Of Higher Learning | Process and apparatus for microCT imaging of ex vivo specimens |
| GB2442290B (en) * | 2006-06-01 | 2011-02-16 | Ana Tec As | A method and an apparatus for analysing objects |
| GB2442290A (en) * | 2006-06-01 | 2008-04-02 | Ana Tec As | Rotating object image analysis |
| NO342936B1 (en) * | 2006-07-19 | 2018-09-03 | Hemocue Ab | Device for capturing an image |
| WO2008010759A1 (en) | 2006-07-19 | 2008-01-24 | Hemocue Ab | Apparatus for capturing an image |
| EP2041581A1 (en) * | 2006-07-19 | 2009-04-01 | Hemocue AB | Apparatus for capturing an image |
| EP2041581A4 (en) * | 2006-07-19 | 2013-09-18 | Hemocue Ab | Apparatus for capturing an image |
| WO2008131840A3 (en) * | 2007-04-26 | 2009-01-22 | Zeiss Carl Microimaging Gmbh | Sample holder for a microscope |
| US8699133B2 (en) | 2007-04-26 | 2014-04-15 | Carl Zeiss Microscopy Gmbh | Sample holding system for a microscope with magnetic coupling |
| WO2008131840A2 (en) * | 2007-04-26 | 2008-11-06 | Carl Zeiss Microimaging Gmbh | Sample holder for a microscope |
| US8693091B2 (en) | 2007-09-03 | 2014-04-08 | Szededi Tudomanyegyetem | Optical microscope system and method carried out therewith for reconstructing an image of an object |
| WO2009030966A1 (en) * | 2007-09-03 | 2009-03-12 | Szegedi Tudományegyetem | Optical microscope system and method carried out therewith for reconstructing an image of an object |
| US8956827B2 (en) | 2010-03-30 | 2015-02-17 | Technische Universitat Wien | Histological method |
| WO2011124317A1 (en) * | 2010-03-30 | 2011-10-13 | Technische Universität Wien | Histological method |
| US9445078B2 (en) | 2011-04-29 | 2016-09-13 | Thrombogenics Nv | Stereo-vision system |
| WO2012146720A1 (en) * | 2011-04-29 | 2012-11-01 | Peira Bvba | Stereo-vision system |
| CN102389291A (en) * | 2011-06-09 | 2012-03-28 | 广西中医学院 | Experimental animal sign information collection and analysis system and collection and analysis method |
| US10921234B2 (en) | 2013-05-28 | 2021-02-16 | Chemometec A/S | Image forming cytometer |
| CN105579828A (en) * | 2013-05-28 | 2016-05-11 | 克莫麦特公司 | Image forming cytometer |
| US10458896B2 (en) | 2013-05-28 | 2019-10-29 | Chemometec A/S | Image forming cytometer |
| EP3004838B1 (en) * | 2013-05-28 | 2022-03-16 | ChemoMetec A/S | Image forming cytometer |
| DE102013210269B8 (en) | 2013-06-03 | 2015-01-29 | Laser Zentrum Hannover E.V. | Apparatus and method for assaying samples in a liquid |
| DE102013210269B3 (en) * | 2013-06-03 | 2014-11-06 | Laser Zentrum Hannover E.V. | Apparatus and method for assaying samples in a liquid |
| WO2019020975A1 (en) * | 2017-07-24 | 2019-01-31 | University College Cardiff Consultants Ltd | Analysing nano-objects |
| US10996159B2 (en) | 2017-07-24 | 2021-05-04 | University College Cardiff Consultants Limited | Analysing nano-objects |
| EP3485976A1 (en) * | 2017-11-21 | 2019-05-22 | Koninklijke Philips N.V. | Method of handling a biopsy sample |
| WO2019101657A1 (en) * | 2017-11-21 | 2019-05-31 | Koninklijke Philips N.V. | Method of handling a biopsy sample |
| CN110673323A (en) * | 2019-10-16 | 2020-01-10 | 西湖大学 | Microscope assembly |
| CN110673323B (en) * | 2019-10-16 | 2021-11-23 | 锘海生物科学仪器(上海)有限公司 | Microscope assembly |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003285523A1 (en) | 2004-06-18 |
| GB0227649D0 (en) | 2003-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7218393B2 (en) | Rotary stage for imaging a specimen | |
| US20060093200A1 (en) | Optical projection tomography | |
| US20140160236A1 (en) | Lensfree holographic microscopy using wetting films | |
| JP2017517761A (en) | Method and apparatus for imaging large intact tissue samples | |
| WO2004048970A1 (en) | Uses of optical projection tomography methods and apparatus | |
| JP6513802B2 (en) | Laser light coupling for nanoparticle detection | |
| JP2020535477A (en) | Real-time autofocus scanning | |
| EP1532443A1 (en) | Optical projection tomography | |
| JP2020536279A (en) | Slide inventory check and reinsert system | |
| CN108700520A (en) | Method and apparatus for high-throughput imaging | |
| CN110967816A (en) | Near-infrared two-zone wide-field microscopic imaging system based on multi-dimensional adjusting frame | |
| JP2020046670A (en) | High-throughput light sheet microscope with adjustable angular illumination | |
| JP2021501349A (en) | Carousel for 2x3 and 1x3 slides | |
| US20240003810A1 (en) | Universal multi-detection system for microplates with confocal imaging | |
| AU2002256798B2 (en) | Rotary stage for imaging a specimen | |
| CN113892042B (en) | Apparatus, system and method for solid immersion meniscus lenses | |
| EP3748414A1 (en) | A simple and efficient biopsy scanner with improved z-axis resolution | |
| WO2020167959A1 (en) | Apparatuses, systems and methods for microscope sample holders | |
| EP4014198A1 (en) | Sample imaging via two-pass light-field reconstruction | |
| AU2002256798A1 (en) | Rotary stage for imaging a specimen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |